Cheap blue dye tested as potential lifesaver for deadly shock
NCT ID NCT06900140
Summary
This study tested whether adding a low-cost, widely available drug called methylene blue to standard care could help adults with septic shock in the intensive care unit. It was a small pilot trial with 50 participants to see if a larger study would be possible. The goal was to see if the drug could reduce the need for blood pressure medications and improve survival or organ recovery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lakeridge Health Ajax-Pickering
Ajax, Ontario, Canada
-
Lakeridge Health Oshawa
Oshawa, Ontario, Canada
Conditions
Explore the condition pages connected to this study.